Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Kaletra Monotherapy in HIV/HCV Co-infected Subjects
NCT00508222Phase 3Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Jun 2007
- Primary completion
- Mar 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Ottawa Hospital Research Institute. Started Jun 2007; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00508222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00508222.